Anti-ob\u00e9sit\u00e9: prescriptions potentiellement \u00e9largies pour plus d’\u00e9quit\u00e9, dit l’ANSM<\/a>\n <\/p>\n\u00ab\u00a0Cette mesure vise \u00e0 faciliter un acc\u00e8s plus \u00e9quitable \u00e0 ces traitements, disponibles uniquement sur ordonnance\u00a0\u00bb, justifie l\u2019ANSM dans un communiqu\u00e9. Les m\u00e9dicaments GLP-1 Wegovy (s\u00e9maglitude), Mounjaro (tirz\u00e9patide) et Saxenda (liraglutide) sont utilis\u00e9s pour traiter l\u2019ob\u00e9sit\u00e9 en\u00a0imitant une hormone digestive.<\/p>\n
Des m\u00e9dicaments sur ordonnance<\/p>\n
Ces m\u00e9dicaments ne peuvent \u00eatre prescrits uniquement sur ordonnance et ne sont donn\u00e9s\u00a0qu'\u00a0\u00bben cas d\u2019\u00e9chec de la prise en charge nutritionnelle, et en association \u00e0 un r\u00e9gime hypocalorique et \u00e0 une activit\u00e9 physique\u00a0\u00bb, rappelle l\u2019ANSM. L\u2019agence\u00a0maintient ainsi\u00a0\u00ab\u00a0une vigilance \u00e9lev\u00e9e sur l\u2019utilisation de ces m\u00e9dicaments et une surveillance renforc\u00e9e et continue des risques associ\u00e9s aux aGLP-1\u00a0\u00bb.<\/p>\n","protected":false},"excerpt":{"rendered":"l’essentiel \u00c0 partir du lundi 23\u00a0juin, tous les m\u00e9decins de France pourront proscrire des m\u00e9dicaments anti-ob\u00e9sit\u00e9, auparavant r\u00e9serv\u00e9s…\n","protected":false},"author":2,"featured_media":193842,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[10],"tags":[1011,27,72,71],"class_list":{"0":"post-193841","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-sante","8":"tag-fr","9":"tag-france","10":"tag-health","11":"tag-sante"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@fr\/114722246797842048","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts\/193841","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/comments?post=193841"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts\/193841\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/media\/193842"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/media?parent=193841"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/categories?post=193841"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/tags?post=193841"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}